AVD regimen (doxorubicin, vindesine, dacarbazine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVD regimen (doxorubicin, vindesine, dacarbazine), covering 2021-04-13 to 2021-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT [Phase 2]